Product information.
Bartlett
J G
JG
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D001424:Bacterial Infections / Q000188:drug therapy*; D001682:Biological Availability; D002214:Capsules; D002986:Clinical Trials as Topic; D020008:Delavirdine / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D005260:Female; D024841:Fluoroquinolones; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011247:Pregnancy; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019258:Saquinavir / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D000890:Anti-Infective Agents; D002214:Capsules; D015507:Drugs, Investigational; D024841:Fluoroquinolones; D017320:HIV Protease Inhibitors; D010879:Piperazines; D011804:Quinolines; D018894:Reverse Transcriptase Inhibitors; D020008:Delavirdine; D019258:Saquinavir